Want to join the conversation?
Biopharmaceutical company $AMGN said the US FDA has issued a Complete Response Letter for the NDA for Parsabiv for treating secondary hyperparathyroidism in adult patients with chronic kidney disease on hemodialysis. Company is reviewing the letter, and anticipates a post-action meeting with the FDA later this year to discuss the response.
Wow! $MCD scores again.
$SPY can the rally continue? La Pen almost assured to lose makes me cautious about the results, not a place to panic. If 2400 is reached I'm selling my puts and going for broke. Happy hunting.
Trivago N.V. (TRVG) announced today that it will release its financial results for the first quarter for the period ended March 31, 2017 on Monday, May 15, 2017. On the same day, trivago N.V.`s management will conduct a webcast beginning at 2:00 PM CET / 8:00 AM Eastern Time. These items will be available in the Investor Relations section of the company`s website at http://ir.trivago.com.